Itragerm (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for converting lanosterol to ergosterol, a key component of the fungal cell membrane. Inhibiting this step disrupts membrane integrity, leading to impaired growth and eventual death of the fungus.

The specific dose of Itragerm is determined by the prescribing clinician based on the type and severity of the fungal infection, patient weight, renal and hepatic function, and other individual factors. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for itraconazole in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To order Itragerm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with other azole antifungals, itraconazole offers a broad spectrum that includes dermatophytes, Candida species and many dimorphic fungi. It has a longer half‑life and higher tissue penetration, especially in keratin‑rich areas, which can make it more effective for nail and skin infections than some alternatives such as fluconazole.

Itragerm should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Itragerm is taken orally, usually with a full glass of water. Depending on the formulation, it may be recommended to take the medication with food to improve absorption, but patients should follow the specific instructions given by their prescriber.

Serious adverse effects include hepatotoxicity (liver injury), severe cardiac arrhythmias such as QT prolongation, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should report symptoms such as yellowing of the skin or eyes, irregular heartbeat, or widespread rash to their healthcare provider promptly.

Itragerm should be avoided in patients with known hypersensitivity to itraconazole or any azole antifungal, in those with severe hepatic impairment, and in individuals taking medications that have a major interaction risk, such as rifampin or certain statins, unless a clinician determines that benefits outweigh the risks.